BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7022923)

  • 1. Migratory behavior of lymphocytes during allograft rejection.
    Hoffman RA; Ascher NL; Simmons RL
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1102-4. PubMed ID: 7022923
    [No Abstract]   [Full Text] [Related]  

  • 2. Maturation of cytotoxic effector cells at the site of allograft rejection.
    Ascher NL; Chen S; Hoffman R; Simmons RL
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1105-7. PubMed ID: 6973856
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of allograft rejection in New Zealand mice. II. Role of a serum factor.
    Gelfand MC; Parker LM; Steinberg AD
    J Immunol; 1974 Jul; 113(1):1-8. PubMed ID: 4598887
    [No Abstract]   [Full Text] [Related]  

  • 4. Recruitment of lymphocytes to sponge matrix allografts.
    Hopt UT; Sullivan W; Simmons RL
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1086-90. PubMed ID: 7022919
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological disease induced by injecting F1 lymphoid cells into certain parental strains.
    Simpson E; O'Hopp S; Harrison M; Mosier D; Melief K; Cantor H
    Immunology; 1974 Dec; 27(6):989-1007. PubMed ID: 4156027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
    Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
    Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor activity of the lymphocytes of BALB/c and C57BL mice during methylcholanthrene carcinogenesis].
    Umanskiĭ IuA; Semenova-Kobzar' RA; Kushko LIa; Tovmachenko NN
    Vopr Onkol; 1976; 22(6):40-4. PubMed ID: 969342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of cytokine production within the rejecting allograft.
    Ford HR; Hoffman RA; Wang SA; Simmons RL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):251-2. PubMed ID: 1990526
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific migration of antigen-sensitive lymphocytes form the spleen to the site of allograft.
    Olszewski WL; Stepkowski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):529-34. PubMed ID: 7036937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
    Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
    J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragraft distribution of lymphocytes expressing beta7 integrins after small bowel transplantation in mice.
    Kellersmann R; Ulrichs K; Kellersmann A; Thiede A
    Transpl Immunol; 2004 Dec; 13(4):249-58. PubMed ID: 15589737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems.
    Chandradasa KD
    Int J Cancer; 1973 May; 11(3):648-62. PubMed ID: 4598551
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA; Kushko LIa; Semenova-Kobzar' RA
    Vopr Onkol; 1980; 26(2):42-6. PubMed ID: 7361493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carrageenan and high serum dilution on synergistic cytotoxicity to tumor cells.
    Pollack S; Nelson K
    J Immunol; 1973 May; 110(5):1440-3. PubMed ID: 4697837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.